Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP). (7th November 2013) - Ascierto, Paolo Antonio; Simeone, E; Sileni, V Chiarion; Queirolo, P; Del Vecchio, M; Di Guardo, L; Guidoboni, M; Marchetti, P; Cappellini, GC Antonini; Ferrucci, PF; Cognetti, F; Bernengo, MG; et al.